Dengue Fever on the Rise: Explore JPT's Dengue Peptide Tools

Published on 16/07/2024

Dengue on the rise

Dengue fever, once considered a tropical disease, it is now spreading beyond subtropical and tropical regions. Belonging to the genus of flavivirdae, this single positive-stranded RNA virus is primarily transmitted through mosquito bites. With cases increasing 10fold in the last 20 years, Dengue is spreading globally. The WHO estimates half the human population being at risk this year.

Current Treatments

As no specific treatment is available, vector and fever control are the main modes of action. However, recently two Dengue vaccines have been FDA approved and one more currently undergoing trials. As such, monitoring immune responses of new outbreaks, new variant emergences, and immunization efficiencies remains crucial.

JPT's Peptide Tools for Dengue Research

To support your research in understanding and combating Dengue, JPT offers anextensive catalog of peptide products:

Explore More

Learn more about other flaviviridae and tropical diseases on our website. If you cannot find your peptide tools of choice, JPT will synthesize your custom peptides, peptide pools or microarrays for you! Providing the largest variety of custom peptide formats, we are confident in our ability to support to your research project!